The use of intravenous glutathione for symptom management of Parkinson’s disease: A case report

Madalyn Otto, Tracy Magerus, Jeffrey Langland

Research output: Contribution to journalArticle

1 Scopus citations


Intravenous glutathione has been suggested empirically to improve Parkinson’s disease (PD) symptoms of tremor and rigidity, but there is limited supporting research. This case report demonstrates both subjective and objective symptom improvement of a conventionally-treated patient suffering from PD when adjunctive intravenous glutathione was administered. In addition to suggesting clinical benefit, this case also suggests an effective therapeutic frequency of therapy and a minimal therapeutic dose. The consistent pattern of improvement following glutathione injections asserts that this therapy may improve symptoms common to PD patients and can offer additional quality of life that would be otherwise unattainable to these patients.

Original languageEnglish (US)
Pages (from-to)56-60
Number of pages5
JournalAlternative Therapies in Health and Medicine
Issue number4
StatePublished - Jul 1 2018


ASJC Scopus subject areas

  • Complementary and alternative medicine

Cite this